Kazia Therapeutics Limited (KZIA)
Nasdaq: KZIA · Pharmaceutical Preparations · filing with the SEC since 2002
Filings
522 filings since 2017 beside 18 insider forms · Non-accelerated filer · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer
20-F
Annual report, foreign filer for the fiscal year ending Jun 30, 2026Foreign filers have four months after the fiscal year ends; no report for this period is on file, and a late-filing notice (Form NT 20-F) was filed Nov 2, 2026.
overdue since Oct 28, 2026
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.
Filings a yearinsider forms included
333429253786107106
2026 counts to Nov 13, 2026.
SEC letters: 16 in the last 36 months, the newest Mar 26, 2026.A late-filing notice, Form NT 20-F, filed Nov 2, 2026.A late-filing notice, Form NT 20-F, filed Oct 31, 2025.A late-filing notice, Form NT 20-F, filed Nov 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 522 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.